285 related articles for article (PubMed ID: 29550520)
1. Nitric oxide and cyclic GMP functions in bone.
Kalyanaraman H; Schall N; Pilz RB
Nitric Oxide; 2018 Jun; 76():62-70. PubMed ID: 29550520
[TBL] [Abstract][Full Text] [Related]
2. The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective.
Krishnan SM; Kraehling JR; Eitner F; Bénardeau A; Sandner P
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890734
[TBL] [Abstract][Full Text] [Related]
3. The NO-cGMP-PKG pathway in skeletal remodeling.
Kim SM; Yuen T; Iqbal J; Rubin MR; Zaidi M
Ann N Y Acad Sci; 2021 Mar; 1487(1):21-30. PubMed ID: 32860248
[TBL] [Abstract][Full Text] [Related]
4. Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.
Wong JC; Fiscus RR
J Cell Biochem; 2011 Mar; 112(3):829-39. PubMed ID: 21328456
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP.
Wykes V; Bellamy TC; Garthwaite J
J Neurochem; 2002 Oct; 83(1):37-47. PubMed ID: 12358727
[TBL] [Abstract][Full Text] [Related]
7. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide as a mediator of estrogen effects in osteocytes.
Joshua J; Kalyanaraman H; Marathe N; Pilz RB
Vitam Horm; 2014; 96():247-63. PubMed ID: 25189390
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
[TBL] [Abstract][Full Text] [Related]
10. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.
Gao Y
J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation.
Ferrero R; Rodríguez-Pascual F; Miras-Portugal MT; Torres M
J Neurochem; 2000 Nov; 75(5):2029-39. PubMed ID: 11032892
[TBL] [Abstract][Full Text] [Related]
12. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
14. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
[TBL] [Abstract][Full Text] [Related]
15. Soluble guanylate cyclase as a novel treatment target for osteoporosis.
Joshua J; Schwaerzer GK; Kalyanaraman H; Cory E; Sah RL; Li M; Vaida F; Boss GR; Pilz RB
Endocrinology; 2014 Dec; 155(12):4720-30. PubMed ID: 25188528
[TBL] [Abstract][Full Text] [Related]
16. Pro-survival effects of 17β-estradiol on osteocytes are mediated by nitric oxide/cGMP via differential actions of cGMP-dependent protein kinases I and II.
Marathe N; Rangaswami H; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Jan; 287(2):978-88. PubMed ID: 22117068
[TBL] [Abstract][Full Text] [Related]
17. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
18. The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review.
Sandner P; Berger P; Zenzmaier C
Gerontology; 2017; 63(3):216-227. PubMed ID: 27784018
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Erdmann J; Stark K; Esslinger UB; Rumpf PM; Koesling D; de Wit C; Kaiser FJ; Braunholz D; Medack A; Fischer M; Zimmermann ME; Tennstedt S; Graf E; Eck S; Aherrahrou Z; Nahrstaedt J; Willenborg C; Bruse P; Brænne I; Nöthen MM; Hofmann P; Braund PS; Mergia E; Reinhard W; Burgdorf C; Schreiber S; Balmforth AJ; Hall AS; Bertram L; Steinhagen-Thiessen E; Li SC; März W; Reilly M; Kathiresan S; McPherson R; Walter U; ; Ott J; Samani NJ; Strom TM; Meitinger T; Hengstenberg C; Schunkert H
Nature; 2013 Dec; 504(7480):432-6. PubMed ID: 24213632
[TBL] [Abstract][Full Text] [Related]
20. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
